Cosmetically nice cash burn situation - actual FY more like -3m though.
Still - if one deal that is supposed to not going to happen occurs then maybe USD2m can cover another year and then another etc
Or if Genentech elect then maybe that is USD2m of the USD142m and so on.
It's not hard to realise that maybe they get past the Bioexec predicted date of 2017 for a CR.
It's nice to know if you want a piece of the action you have to buy on market for the next couple of years.
Cosmetically nice cash burn situation - actual FY more like -3m...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |